WallStreetBets goes to Wall Street as Reddit files for IPO-
GBA Presents: THE GREEN MARKET
- Thread starter stonedinvestor
- Start date
hahahah
you know damn well i've been posting in "the new #1 thread on the worldwide intrawebs".
Pffff
@Overnight... That is possibly the stupidest post you have ever made. I am 10,000X more in tune with the big picture than any stock. You have no f'ing idea what I trade and when. I keep it that way.
F/A of stocks is the easy part, knowing what the herd will do before it does it, that's takes a savant. Pretty sure I'm 11 for 12 on the ES thread. Yesterday I missed, albeit it did drop significantly before it rocketed up. But that was still a bad call on my part.
As I said, we'll spike up, but we'll be lower soon enough. 480 on the Q's will fall.
I'll tell you right now- One Theme I am working on.
I believe Jan Feb will be HUGE for retail.
This is because of so much merch that did not make it to the shelves in time for Christmas.
All those delayed cargo ships. It is going to result in amazing selections of product at various retailers in an unusually dormant time.
Just take Sony for example. I managed to get a PS-5. I had to overpay a high schoolkid to hack it. You cannot buy directly from Sony i tried.
When six million units flop on our shores too late for Christmas.. They are not going to sit on the shelves. I see less returns this year because of sale items and old merch and a lot of Retail action Jan Feb.
So a name like Foot Locker you want to time it and get in.
I believe Jan Feb will be HUGE for retail.
This is because of so much merch that did not make it to the shelves in time for Christmas.
All those delayed cargo ships. It is going to result in amazing selections of product at various retailers in an unusually dormant time.
Just take Sony for example. I managed to get a PS-5. I had to overpay a high schoolkid to hack it. You cannot buy directly from Sony i tried.
When six million units flop on our shores too late for Christmas.. They are not going to sit on the shelves. I see less returns this year because of sale items and old merch and a lot of Retail action Jan Feb.
So a name like Foot Locker you want to time it and get in.
VIX only at 18?
- Analyst Beth Reed believes that retail stocks should be stronger coming out of the pandemic due to a roughly 5-year pull-forward in e-commerce adoption and lower inventories causing fewer promotions, both of which should result in higher margins. Additionally, the bankruptcies of smaller companies leaves room for the major chains to become even bigger.
- Bentley Systems (BSY), rated buy with a $65 price target, is likely to also benefit from a boost in infrastructure spending and could benefit from recent M&A activity in "strategic areas."
- Xiaobai Maimai changes name to Akso Health lol Why not just change it to
- WE AMERICAN HEALTH
Audacy gains 5% as B. Riley upgrades with bad news 'priced in'
Van the #1 search this morn is DOCU<-----
Van the #1 search this morn is DOCU<-----
I can't believe FL hasn't bounced.
Went in one last weekend and the f'r was packed.
As soon as I see some option activity on that one, I'm in because when it does spike up, it'll happen fast.
Put it on the list.
EDIT: Use THO too. Or WGO
<< IN THE SWEET SPOT >>
Are we in the sweet spot right now? Omicrom is multiplying at a frightening level it is just a matter of time before one of two things happens.
1- So many people test positive that the economy falters. Quarantine rules will have to be reassessed. Heath facilities become overwhelmed by sheer numbers even if they are not dying.
2- We tough out this winter and when our guard is down in the Spring face a surprising and massive outbreak.
For Now
Delta CEO 'very optimistic' about spring, summer travel, Bastian tells CNBC »07:27 DAL
--Wells Fargo upgrades Magna to Overweight, raises price target to $93
Magna IS THE TYPE OF STOCK I WANT TO BE BUYING******* MANUFACTURERS WHO FEED INTO SOMETHING... COULD THEY BUILD THE APPLE CAR?
--Switch initiated with an Outperform at RBC Capital 07:06 SWCH RBC Capital analyst Jonathan Atkin initiated coverage of Switch with an Outperform rating and $30 price target. The company is seeing solid momentum across multiple market segments, with bandwidth products that provide favorable differentiation vs. many of its peers, the analyst tells investors in a research note. Switch's coming REIT conversion can broaden the shareholder base, which could also support a higher valuation, Atkin adds.
People like Switch. REIT conversion bares watching.
--Safe-T executives complete open market purchases of shares 07:04 SFET Safe-T Group announced…
----Kopin upgraded to Buy from Neutral at H.C. Wainwright 06:06 KOPN
--uniQure announces update on first patients in Phase I/II trial of AMT-130 07:04 QURE uniQure N.V. announced initial observations on the first four patients enrolled in the lower-dose cohort of its ongoing Phase I/II clinical trial of AMT-130 for the treatment of Huntington's disease. Two of the four enrolled patients received AMT-130, and two patients experienced an imitation surgery in this randomized, blinded clinical trial being conducted in the United States. One-Year Observations on AMT-130: The first four patients were a heterogeneous group representing a spectrum of Stage I-II early manifest disease with 41-44 CAG repeats, baseline Total Functional Capacity scores of 10-13 and Total Motor Scores of 7-23. Results: AMT-130 was generally well tolerated in the treated patients at the lower dose; there have been no serious adverse events to date; NfL increased immediately following the AMT-130 surgical procedure and returned to baseline in the two treated patients; structural magnetic resonance imaging did not reveal any clinically meaningful safety findings; measurements of total and mutant HTT protein in the cerebral spinal fluid of the four patients were highly variable and inconclusive; The safety profile of AMT-130 in the low-dose cohort to date supports continued enrollment of patients in the higher-dose cohort...
--Apple's iPhone sales decelerating in China, DigiTimes reports
What happens in Jan> Apple Falls.
Are we in the sweet spot right now? Omicrom is multiplying at a frightening level it is just a matter of time before one of two things happens.
1- So many people test positive that the economy falters. Quarantine rules will have to be reassessed. Heath facilities become overwhelmed by sheer numbers even if they are not dying.
2- We tough out this winter and when our guard is down in the Spring face a surprising and massive outbreak.
For Now
Delta CEO 'very optimistic' about spring, summer travel, Bastian tells CNBC »07:27 DAL
--Wells Fargo upgrades Magna to Overweight, raises price target to $93
Magna IS THE TYPE OF STOCK I WANT TO BE BUYING******* MANUFACTURERS WHO FEED INTO SOMETHING... COULD THEY BUILD THE APPLE CAR?
--Switch initiated with an Outperform at RBC Capital 07:06 SWCH RBC Capital analyst Jonathan Atkin initiated coverage of Switch with an Outperform rating and $30 price target. The company is seeing solid momentum across multiple market segments, with bandwidth products that provide favorable differentiation vs. many of its peers, the analyst tells investors in a research note. Switch's coming REIT conversion can broaden the shareholder base, which could also support a higher valuation, Atkin adds.
People like Switch. REIT conversion bares watching.
--Safe-T executives complete open market purchases of shares 07:04 SFET Safe-T Group announced…
----Kopin upgraded to Buy from Neutral at H.C. Wainwright 06:06 KOPN
--uniQure announces update on first patients in Phase I/II trial of AMT-130 07:04 QURE uniQure N.V. announced initial observations on the first four patients enrolled in the lower-dose cohort of its ongoing Phase I/II clinical trial of AMT-130 for the treatment of Huntington's disease. Two of the four enrolled patients received AMT-130, and two patients experienced an imitation surgery in this randomized, blinded clinical trial being conducted in the United States. One-Year Observations on AMT-130: The first four patients were a heterogeneous group representing a spectrum of Stage I-II early manifest disease with 41-44 CAG repeats, baseline Total Functional Capacity scores of 10-13 and Total Motor Scores of 7-23. Results: AMT-130 was generally well tolerated in the treated patients at the lower dose; there have been no serious adverse events to date; NfL increased immediately following the AMT-130 surgical procedure and returned to baseline in the two treated patients; structural magnetic resonance imaging did not reveal any clinically meaningful safety findings; measurements of total and mutant HTT protein in the cerebral spinal fluid of the four patients were highly variable and inconclusive; The safety profile of AMT-130 in the low-dose cohort to date supports continued enrollment of patients in the higher-dose cohort...
--Apple's iPhone sales decelerating in China, DigiTimes reports
What happens in Jan> Apple Falls.
Thor Industries director Orthwein buys 10,000 common shares 16:40 THO In a regulatory filing, Thor Industries director Peter Busch Orthwein disclosed the purchase of 10,000 common shares of the company on December 10 at a price of $103.41 per share.Yest
Bentley Systems price target lowered to $65 from $74 at Mizuho 06:50 BSY Mizuho analyst Matthew Broome lowered the firm's price target on Bentley Systems to $65 from $74 and keeps a Buy rating on the shares. The analyst enters 2022 with "guarded optimism" on the software sector.
YET Bentley is mentioned as a stk to own for 2022 by analyst above- $65 target.
This guy too- $65.
Stk- $48!<------------------ VAN-!
Bentley Systems price target lowered to $65 from $74 at Mizuho 06:50 BSY Mizuho analyst Matthew Broome lowered the firm's price target on Bentley Systems to $65 from $74 and keeps a Buy rating on the shares. The analyst enters 2022 with "guarded optimism" on the software sector.
YET Bentley is mentioned as a stk to own for 2022 by analyst above- $65 target.
This guy too- $65.
Stk- $48!<------------------ VAN-!
-WATCH-
MTTR-
BSY-
THO-
QURE-
MGA-
<<< >>>
THESE ARE 3 TECH POWERHOUSES TO WATCH I HAVE THEM IN ORDER OF CHART STABILITY.
SAIL-
DOMO-
FIVN-
***Magna International Inc. (MGA)- Holy crap at a 52 week high. Really?
77.70+0.69(+0.90%)
MTTR-
BSY-
THO-
QURE-
MGA-
<<< >>>
THESE ARE 3 TECH POWERHOUSES TO WATCH I HAVE THEM IN ORDER OF CHART STABILITY.
SAIL-
DOMO-
FIVN-
***Magna International Inc. (MGA)- Holy crap at a 52 week high. Really?
77.70+0.69(+0.90%)